Valuation: 3SBio Inc.

Market Cap 37.74B 43.91B 5.6B 4.85B 4.54B 4.14B 7.79B 534B 7.91B 53.43B 20.88B 267B 21.01B 20.55B 891B P/E 2026 *
14.4x
P/E 2027 * 14.3x
Enterprise Value 25.11B 29.21B 3.72B 3.23B 3.02B 2.76B 5.18B 355B 5.26B 35.54B 13.89B 178B 13.98B 13.67B 593B EV / Sales 2026 *
2.48x
EV / Sales 2027 * 2.25x
Free-Float
74.94%
Yield 2026 *
1.58%
Yield 2027 * 1.71%
1 day-0.96%
1 week+4.69%
Current month+5.38%
1 month-2.49%
3 months-18.58%
6 months-26.95%
Current year-27.13%
1 week 17.02
Extreme 17.02
18.96
1 month 15.61
Extreme 15.61
19.13
Current year 14.81
Extreme 14.81
29.3
1 year 14.81
Extreme 14.81
36.8
3 years 4.91
Extreme 4.91
36.8
5 years 4.72
Extreme 4.72
36.8
10 years 4.72
Extreme 4.72
36.8
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2006
Director of Finance/CFO 43 03/07/2023
Corporate Officer/Principal 56 27/11/2014
Director TitleAgeSince
Chairman 63 03/04/2012
Director/Board Member 56 11/06/2012
Director/Board Member 57 01/06/2015
Date Insider Type Main position Quantity % Market Cap.
29/07/25 Other

Chief Executive Officer

440,000 0.0184%
15/04/25 Other

Director

26,000 0.0011%
11/04/25 Other

Director

460,000 0.0192%
Change 5-day change 1-year change 3-year change Capi.($)
-0.96%+4.69%-42.19%+151.00% 5.65B
+0.12%+3.83%+43.38%-1.29% 79.58B
-3.73%+4.95%-2.38%+25.77% 52.73B
-1.95%-0.67%+18.86%+170.42% 49.77B
+0.08%+7.46%-47.52%-47.97% 46.77B
+2.44%+1.08%+62.00%-23.42% 30.13B
-0.25%+0.81%+47.98%+85.12% 24.54B
+5.12%+13.18%+148.13%-36.33% 24.18B
0.00%+10.21%+6.23%+188.24% 21.2B
+0.17%+2.26%+70.79%+165.74% 16.36B
Average +0.12%+3.81%+30.53%+67.73% 35.09B
Weighted average by Cap. -0.25%+3.67%+27.71%+44.33%

Financials

2026 *2027 *
Net sales 10.11B 11.76B 1.5B 1.3B 1.22B 1.11B 2.09B 143B 2.12B 14.31B 5.59B 71.57B 5.63B 5.5B 239B 10.43B 12.14B 1.55B 1.34B 1.26B 1.15B 2.15B 148B 2.19B 14.77B 5.77B 73.88B 5.81B 5.68B 246B
Net income 2.68B 3.11B 397M 344M 322M 294M 552M 37.84B 561M 3.79B 1.48B 18.95B 1.49B 1.46B 63.18B 2.69B 3.14B 400M 346M 324M 296M 556M 38.1B 565M 3.81B 1.49B 19.08B 1.5B 1.47B 63.62B
Net Debt -12.63B -14.7B -1.87B -1.62B -1.52B -1.39B -2.61B -179B -2.65B -17.88B -6.99B -89.45B -7.03B -6.88B -298B -14.26B -16.6B -2.12B -1.83B -1.72B -1.57B -2.94B -202B -2.99B -20.19B -7.89B -101B -7.94B -7.77B -337B
Logo 3SBio Inc.
3SBio Inc is an investment holding company principally engaged in the development, production, marketing and sale of biopharmaceutical products. The Company's main products include biopharmaceuticals such as TPIAO, EPIAO, Yisaipu, and Cipterbin, as well as small moleculessuch as Mandi and Remitch. The Company is also engaged in the contract development and manufacturing operations (CDMO) business that provides customers with research, development and production of a variety of biopharmaceuticals and therapeutic technology platform services. The Company's products are mainly used for chemotherapy-induced thrombocytopenia (CIT), anemia caused by chronic kidney disease (CKD), treatment of chemotherapy-induced anemia (CIA), ankylosing spondylitis (AS) and psoriasis. The Company mainly operates its businesses in the domestic and overseas markets.
Employees
6,109
Date Price Change Volume
12/08/26 HK$17.62 -0.96% 14,687,498
11/08/26 HK$17.79 -1.17% 23,915,782
10/08/26 HK$18.00 +0.17% 29,527,456
07/08/26 HK$17.97 +4.60% 25,868,872
06/08/26 HK$17.18 -0.23% 12,092,173
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
15.14CNY
Average target price
28.10CNY
Spread / Average Target
+85.55%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1530 Stock